Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Altman

Showing results (241-250 of 365) with videos related to

Pageof 37
Sort By:
Blood Neoplasia|February 13, 2026
FLT3 as a germ line driver in AML: expanding the landscape of leukemia predispositionAlok Swaroop, Natasha L Johnson, Michelle C Tophkhane, et al.
Pediatric Research|December 3, 2008
Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formationTroy D Pashuck, Sarah E Franz, Molly K Altman, et al.
Molecular Cancer Therapeutics|October 26, 2014
Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursorsElspeth M Beauchamp, Ewa M Kosciuczuk, Ruth Serrano, et al.
Molecular Metabolism|February 7, 2018
TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretionNicholas C Vierra, Matthew T Dickerson, Kelli L Jordan, et al.
Science Signaling|April 7, 2021
Input-specific regulation of glutamatergic synaptic transmission in the medial prefrontal cortex by mGlu<sub>2</sub>/mGlu<sub>4</sub> receptor heterodimersZixiu Xiang, Xiaohui Lv, Xin Lin, et al.
Oncotarget|September 17, 2015
Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemiasDany A Curi, Elspeth M Beauchamp, Gavin T Blyth, et al.
Cardiology in Review|August 15, 2015
Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled TrialsShashi Kumar, Stephan B Danik, Robert K Altman, et al.
European Journal of Haematology|March 28, 2025
Clinicopathologic Characteristics and Prognostic Profile of Chronic Myeloid Neoplasms With Somatic NF1 Mutations in Adult PatientsHamza Tariq, Margarita Loxas, Mir B Alikhan, et al.
Haematologica|December 2, 2021
A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemiaSumithira Vasu, Jessica K Altman, Geoffrey L Uy, et al.
Blood|March 20, 2013
Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursorsJessica K Altman, Amy Szilard, Bruce W Konicek, et al.
Pageof 37

Showing results (241-250 of 365) with videos related to

Sort By:
Pageof 37
Blood Neoplasia|February 13, 2026
FLT3 as a germ line driver in AML: expanding the landscape of leukemia predispositionAlok Swaroop, Natasha L Johnson, Michelle C Tophkhane, et al.
Pediatric Research|December 3, 2008
Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formationTroy D Pashuck, Sarah E Franz, Molly K Altman, et al.
Molecular Cancer Therapeutics|October 26, 2014
Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursorsElspeth M Beauchamp, Ewa M Kosciuczuk, Ruth Serrano, et al.
Molecular Metabolism|February 7, 2018
TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretionNicholas C Vierra, Matthew T Dickerson, Kelli L Jordan, et al.
Science Signaling|April 7, 2021
Input-specific regulation of glutamatergic synaptic transmission in the medial prefrontal cortex by mGlu<sub>2</sub>/mGlu<sub>4</sub> receptor heterodimersZixiu Xiang, Xiaohui Lv, Xin Lin, et al.
Oncotarget|September 17, 2015
Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemiasDany A Curi, Elspeth M Beauchamp, Gavin T Blyth, et al.
Cardiology in Review|August 15, 2015
Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled TrialsShashi Kumar, Stephan B Danik, Robert K Altman, et al.
European Journal of Haematology|March 28, 2025
Clinicopathologic Characteristics and Prognostic Profile of Chronic Myeloid Neoplasms With Somatic NF1 Mutations in Adult PatientsHamza Tariq, Margarita Loxas, Mir B Alikhan, et al.
Haematologica|December 2, 2021
A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemiaSumithira Vasu, Jessica K Altman, Geoffrey L Uy, et al.
Blood|March 20, 2013
Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursorsJessica K Altman, Amy Szilard, Bruce W Konicek, et al.
Pageof 37